Humanwell Pharmaceutical

Humanwell Healthcare is a leading China-based pharmaceutical company and global supplier, specializing in anesthetics, pain management, fertility regulation, CNS treatments, and generic drugs. Many products are marketed; over 20 pipeline drugs are in clinical–commercial stages, with several new chemical entities (NCEs), ANDAs, and 505(b)(2) projects in late development and trials. US subsidiary Humanwell Pharmaceutical US, Inc. recently began Phase 1 for its first FDA NDA project, and the group is expanding globally including to the US, Europe, and Africa. The group is notable for a wide range of modalities and a strong manufacturing base[1][3][6][5][4].